Kymera Therapeutics Other Long Term Liabilities (Quarterly) Analysis

Kymera Therapeutics, Inc. (KYMR)

75.29 +1.16 (+1.56%) USD | NASDAQ | Jan 14, 16:00

75.29 0.00 (0.00%) After-Hours: 17:34

View Other Long Term Liabilities (Quarterly) for KYMR.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Other Long Term Liabilities (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Other Long Term Liabilities (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Other Long Term Liabilities (Quarterly) Benchmarks

Start Trial

Regeneron Pharmaceuticals, Inc.	Upgrade
Gilead Sciences, Inc.	Upgrade
Cytokinetics, Inc.	Upgrade
TG Therapeutics, Inc.	--
Protagonist Therapeutics, Inc.	--